/PRNewswire/ Dewpoint Therapeutics, Inc. today announced biomolecular scientist Anthony Hyman, head of the Max Planck Institute of Molecular Cell Biology.
/PRNewswire/ Dewpoint Therapeutics, Inc., the biomolecular condensates company, today announced the completion of a $150 million Series C financing. The.
/PRNewswire/ Dewpoint Therapeutics, Inc., the biomolecular condensates company, today announced the completion of a $150 million Series C financing. The.
Dewpoint Raises $150 Million to Advance Pipeline of Biomolecular Condensate Candidates globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.